They focused on the mitotic checkpoint kinase BUB1 as a direct MYB downstream target [103] and showed that the selective BUB1 inhibitor BAY1816032 caused the growth arrest and apoptosis of patient-derived ACC cells. Here, BUB1 is linked to adrenal cortex carcinoma.